| Pharmaceutical active ingredients: |
| Epinephrine Hydrochloride Racemic |
| Available forms, composition and doses of Vaponefrin: |
| Solution; Inhalation; Epinephrine Hydrochloride, Racemic 2.25% |
| Vaponefrin medical category: |
| Human:Alpha- and beta-adrenergic agonistsCardiac drugsDental agentsMydriaticsNasal decongestantsSympathomimetic (adrenergic) agentsTopical sympathomimetic agentsVasoconstrictors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R03AA01 - Epinephrine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisCelltech |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Sil Trax Epi No 9 | Epinephrine Hydrochloride Racemic | Pascal International Corporation |
| Siltrax Epi 7 | Epinephrine Hydrochloride Racemic | Pascal International Corporation |
| Sulpak R34 | Epinephrine Hydrochloride Racemic | North Pacific Dental |
| Sulpak R35 | Epinephrine Hydrochloride Racemic | North Pacific Dental |
| Sulpak R36 | Epinephrine Hydrochloride Racemic | North Pacific Dental |
| Racord Two 7 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |
| Racord Two No. 10 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |
| Racord Two No. 8 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |
| Racord Two No. 9 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |
| Sil Trax plus No. 10 | Epinephrine Hydrochloride Racemic; Zinc Phenolsulphonate | Pascal International Corporation |